SCHEMBL1704801

SCHEMBL1704801

NC1CCN(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
SIGMAR1 Q99720 2/20 0.62
HTR3E A5X5Y0 1/20 0.62
HTR3B O95264 1/20 0.62
HTR1D P28221 1/20 0.62
HTR2C P28335 1/20 0.62
HTR3A P46098 1/20 0.62
HTR3D Q70Z44 1/20 0.62
HTR3C Q8WXA8 1/20 0.62
MAPT P10636 4/20 0.60
THRB P10828 1/20 0.60
NOTUM Q6P988 1/20 0.58
POLB P06746 1/20 0.56
IDH2 P48735 1/20 0.55
HRH3 Q9Y5N1 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.52
LMNA P02545 2/20 0.52
HTT P42858 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52
CYP1A2 P05177 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL9310896 0.98 ALDH1A1 (0.60) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL2854862 0.91 NOTUM (0.63) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL21624885 0.91 NOTUM (0.63) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
Hydrochloric Acid SCHEMBL9312337 0.89 NOTUM (0.61) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL28226906 0.84 ALDH1A1 (0.77) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL9310553 0.82 IDH2 (0.59) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL3844094 0.81 DRD2 (0.67) ALDH1A1SIGMAR1MAPTSMN1; SMN2NPSR1
SCHEMBL17754046 0.81 ALDH1A1 (0.59) ALDH1A1SIGMAR1HTR3EHTR3BHTR1D
SCHEMBL13613092 0.81 POLB (0.66) ALDH1A1NOTUMPOLBSMN1; SMN2LMNA
SCHEMBL13758466 0.81 POLB (0.66) ALDH1A1NOTUMPOLBSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130317041-A1 COMPOUNDS GLAXO GROUP LIMITED (GB) 2013-11-28 US disclosed
US-8536182-B2 Benzylpiperazine derivatives and their medical use GLAXO GROUP LIMITED (GB) 2013-09-17 US disclosed
EP-1907374-B1 Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders GLAXO GROUP LTD (GB) 2012-08-22 EP disclosed
EP-2441763-A1 Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders Glaxo Group Limited (GB) 2012-04-18 EP disclosed
US-20090054456-A1 BENZYLPIPERAZINE DERIVATIVES AND THEIR MEDICAL USE GLAXO GROUP LIMITED (GB) 2009-02-26 US disclosed
EP-1907374-A2 COMPOUNDS GLAXO GROUP LIMITED (GB) 2008-04-09 EP disclosed
WO-2007012479-A2 BENZYLPIPERAZINE DERIVATES AND THEIR MEDICAL USE GLAXO GROUP LIMITED (GB) 2007-02-01 WO disclosed
EP-0156433-B1 ANTI-VIRALLY ACTIVE PYRIDAZINAMINES JANSSEN PHARMACEUTICA N.V. (BE) 1991-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054456-A1 BENZYLPIPERAZINE DERIVATIVES AND THEIR MEDICAL USE GPR68, GPR88, GPR55 ALDH1A1 1817/4885SIGMAR1 329/4885HTR3E 301/4885
US-20130317041-A1 COMPOUNDS GPR68, GPR88, GPR35 ALDH1A1 1802/4885SIGMAR1 474/4885HTR3E 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.